Soluble Programmed Death-Ligand 1 (sPD-L1) is Elevated in Aggressive Prostate Cancer Disease Among African Men.

Paul KatongoleObondo J SandeSteven J ReynoldsMoses JolobaHenry KajumbulaSamuel KalungiKenneth SsebambuliddeCynthia NakimuliMaxine AtuheirweJackson OremNixon Niyonzima

Published in: Oncology and therapy (2022)

Elevated PD-L1 levels were statistically significantly linked to high Gleason scores. These results may guide clinicians in assessing the prognosis of patients individually and selecting patients who will be suitable candidates for anti-PD-L1 immunotherapy.

Keyphrases

prostate cancer
end stage renal disease
radical prostatectomy
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
palliative care
peritoneal dialysis